Mitesco, Inc. MITI
We take great care to ensure that the data presented and summarized in this overview for Mitesco, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in MITI
Top Purchases
Top Sells
About MITI
Mitesco, Inc. operates medical clinics under the The Good Clinic name in North East Minneapolis, the United States. It offers wellness coaching, behavioral health care, episodic care, dermatologic services, and supplements. The company was formerly known as True Nature Holding, Inc. and changed its name to Mitesco, Inc. in April 2020. Mitesco, Inc. is based in Saint Louis Park, Minnesota.
Insider Transactions at MITI
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 15
2025
|
Mack Rimmer Leath Jr. CEO |
BUY
Grant, award, or other acquisition
|
Direct |
1,471
+0.52%
|
$0
$0.34 P/Share
|
|
Jan 15
2025
|
Jordan Paul Balencic Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,471
+0.56%
|
$0
$0.34 P/Share
|
|
Jan 15
2025
|
John Gormer Mitchell Jr. Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,471
+0.49%
|
$0
$0.34 P/Share
|
|
Dec 15
2024
|
Mack Rimmer Leath Jr. CEO |
BUY
Grant, award, or other acquisition
|
Direct |
1,250
+0.45%
|
$0
$0.4 P/Share
|
|
Dec 15
2024
|
Jordan Paul Balencic Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,250
+0.48%
|
$0
$0.4 P/Share
|
|
Dec 15
2024
|
John Gormer Mitchell Jr. Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,250
+0.41%
|
$0
$0.4 P/Share
|
|
Nov 15
2024
|
Jordan Paul Balencic Director |
BUY
Grant, award, or other acquisition
|
Direct |
909
+0.35%
|
$0
$0.55 P/Share
|
|
Nov 15
2024
|
Mack Rimmer Leath Jr. CEO |
BUY
Grant, award, or other acquisition
|
Direct |
909
+0.33%
|
$0
$0.55 P/Share
|
|
Nov 15
2024
|
John Gormer Mitchell Jr. Director |
BUY
Grant, award, or other acquisition
|
Direct |
909
+0.3%
|
$0
$0.55 P/Share
|
|
Nov 13
2024
|
Jordan Paul Balencic Director |
BUY
Grant, award, or other acquisition
|
Direct |
150,877
+18.66%
|
$301,754
$2.29 P/Share
|
|
Nov 13
2024
|
John Gormer Mitchell Jr. Director |
BUY
Grant, award, or other acquisition
|
Direct |
150,877
+16.93%
|
$301,754
$2.29 P/Share
|
|
Nov 13
2024
|
Mack Rimmer Leath Jr. CEO |
BUY
Grant, award, or other acquisition
|
Direct |
150,877
+17.84%
|
$301,754
$2.29 P/Share
|
|
Oct 28
2024
|
Mack Rimmer Leath Jr. CEO |
BUY
Grant, award, or other acquisition
|
Direct |
18,052
+12.7%
|
$72,208
$4.0 P/Share
|
|
Oct 28
2024
|
John Gormer Mitchell Jr. Director |
BUY
Grant, award, or other acquisition
|
Direct |
27,040
+15.54%
|
$108,160
$4.0 P/Share
|
|
Sep 16
2024
|
Jordan Paul Balencic Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,875
+1.74%
|
$0
$0.8 P/Share
|
|
Jul 29
2024
|
Mack Rimmer Leath Jr. CEO |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+48.86%
|
$0
$0.25 P/Share
|
|
Jul 29
2024
|
Jordan Paul Balencic Director |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+49.08%
|
$0
$0.25 P/Share
|
|
Jul 29
2024
|
John Gormer Mitchell Jr. Director |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+45.89%
|
$0
$0.25 P/Share
|
|
Jun 26
2024
|
Mack Rimmer Leath Jr. CEO |
BUY
Grant, award, or other acquisition
|
Direct |
1,875
+28.59%
|
$0
$0.8 P/Share
|
|
Jun 26
2024
|
Jordan Paul Balencic Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,875
+33.33%
|
$0
$0.8 P/Share
|
Last 12 Months Summary
| Grant, award, or other acquisition | 822K shares |
|---|